This Medical Moment – Facial Recognition in Rare Diseases – interviewing Dekel Gelbman

December 1, 2020

Precision Effect 

“On average, a patient with a rare disease takes 4.8 years to find a correct diagnosis. For patients and families searching for answers, this wait can be agonizing. FDNA’s Face2Gene technology is helping to change the standard of care and shorten the time to diagnosis – all through the use of a smartphone.”

 

The article highlights the innovative use of FDNA technology in the realm of rare disease diagnosis, spotlighting its transformative potential. Employing advanced facial recognition algorithms, FDNA’s technology assists clinicians in identifying rare genetic disorders by analyzing patients’ facial features. This groundbreaking approach significantly enhances diagnostic accuracy and speed, offering a beacon of hope for individuals with elusive conditions. Through the lens of facial recognition in rare diseases, the article highlights the importance of integrating artificial intelligence into medical practice, thereby revolutionizing patient care and promoting timely, precise interventions.

Related articles

AI in genetic diagnosis

The Evolution of FDNA’s technology: An Interview with Aviram Bar Haim

Analyzing facial features has long been a vital step in diagnosing genetic syndromes. In recent years, AI-driven technologies have transformed this process, making it more efficient and accurate. Leading this innovation is Face2Gene, an advanced AI platform that leverages machine learning to assist clinicians in identifying genetic disorders. To explore the development of this groundbreaking […]

Continue reading
Genetic Research in Africa: An Interview

Genetic Research in Africa: An Interview with Dr. Aime Lumaka

Dr. Aime Lumaka, a distinguished geneticist from the Democratic Republic of Congo, is at the forefront of advancing genetic research across Africa. As a pivotal figure in the Deciphering Developmental Disorders in Africa (DDD-Africa) initiative and the Principal Investigator of the African Rare Diseases Initiative (ARDI), Dr Lumaka is leading efforts to evaluate clinical exome sequencing in […]

Continue reading